#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell type acute leukaemia Plasma cell myeloma refractory Philadelphia positive acute lymphocytic leukaemia Rhabdomyosarcoma recurrent Fibrosarcoma Fibrous dysplasia of bone Myotonic dystrophy Lymphoma Neuronal ceroid lipofuscinosis Adult T-cell lymphoma/leukaemia refractory Penile squamous cell carcinoma Non-Hodgkin's lymphoma Leukoencephalopathy Colon cancer Rectal cancer More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Diagnostics Noonan syndrome Myelodysplastic syndrome Lymphatic malformation – Treatment Osteosarcoma recurrent – Basic Information Anaplastic thyroid cancer – Treatment Lymphangiosarcoma – Life with Disease Osteosarcoma recurrent Medulloblastoma recurrent – Life with Disease Undifferentiated sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taurine Dexamethasone Acetate Ph. Eur. Bifikafusp Alfa Specific Nucleic Acid Sna-Her2 Dicloxacillin Phenobarbital Vusolimogene Oderparepvec Gtaexs617 Carbasalate Calcium Eplerenone Cilazapril Sar444656 Poa Pratensis Pollen Extract Opium, Standardized Powdered FERUMOXTRAN-10 Tofersen Omp10 Ibrexafungerp Enasidenib Mesilate Finasteride More therapies…

    Learn about Your Condition

    Major depression Henoch-Schonlein purpura Prolymphocytic leukaemia Arterial tortuosity syndrome Hepatic adenoma Klinefelter's syndrome Metastases to biliary tract Metastases to rectum Cleft lip and palate Rhabdoid tumour of the kidney Psychogenic seizure Lumbosacral radiculopathy Head and neck cancer Thrombocytosis Behcet's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DETEMIR
    • Insulin Icodec
    • INSULIN DEGLUDEC
    Germany Italy

  • Study of dronabinol and cannabidiol oral solution for symptom relief in advanced cancer patients receiving opioid treatment

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cancer pain
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Italy

  • Study of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Tucatinib
    • Trastuzumab
    France

  • Study of Cannabidiol and Nutritional Supplements to Improve Muscle Health in Adults with Head and Neck Cancer Before Surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Cannabidiol
    • Placebo
    France

  • Comparing Lung Perfusion PET/CT-Guided Versus Standard Planning for Stereotactic Body Radiotherapy in Patients with Primary or Secondary Lung Tumors

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Human Albumin As Macroaggregates
    • Gallium (68Ga)
    France

  • A Study of Oxytocin Nasal Spray to Reduce Psychological Stress in Women Who Have Recovered from Breast Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stress
    • Breast cancer female
    Investigated Drugs:
    • Oxytocin
    Belgium
Previous Page
1 … 772 773 774 775 776 … 1,659
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!